Last updated on August 2018

Efficacy and Safety of COMBIGAN in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)


Brief description of study

The objective of this study is to evaluate the long-term efficacy and safety of COMBIGAN® (brimonidine tartrate/timolol malate) in patients only using COMBIGAN® (brimonidine tartrate/timolol malate) and also in patients who require additional IOP lowering with LUMIGAN® (bimatoprost) 0.01%.

Clinical Study Identifier: NCT02863705

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Registry Team

Seoul National University Hospital, Seoul National University College of Medicine
Seoul, Korea, Republic of
2.06miles

Clinical Trials Registry Team

Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul, Korea, Republic of
2.06miles

Clinical Trials Registry Team

Asan Medical Center, University of Ulsan College of Medicine
Seoul, Korea, Republic of
2.06miles

Clinical Trials Registry Team

Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine
Seoul, Korea, Republic of
2.06miles

Clinical Trials Registry Team

Kim's Eye Hospital, Konyang University College of Medicine
Seoul, Korea, Republic of
2.06miles